Coastal Infusion Administers Tepezza®

Tepezza (teprotumumab) is used to treat thyroid eye disease (TED), a rare and serious autoimmune disorder that affects the eyes. TED involves inflammation and swelling of the tissues around the eyes, leading to symptoms such as proptosis (bulging eyes), double vision, and pain.

Tepezza is a monoclonal antibody, designed to target and bind to specific molecules in the body. It targets the insulin-like growth factor 1 receptor (IGF-1R), which plays a role in the inflammation and tissue expansion observed in thyroid eye disease. By blocking this receptor, Tepezza helps mitigate the underlying autoimmune processes, reducing inflammation and improving the symptoms associated with TED.

What It Treats

Tepezza is used to treat Thyroid Eye Disease (TED).

Prescribed By

• Ophthalmologists
• Endocrinologists

How it’s Administered

Tepezza is administered by intravenous infusion. Tepezza infusions take about 90 minutes.

Frequency

Tepezza is generally administered every 3 weeks for 8 total infusions.

Additional Resources

• Tepezza Website
• Prescribing Information
• Co-Pay Assistance

The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies